|
1
|
Boyero L, Sánchez-Palencia A, Miranda-Leon
MT, Hernandez-Escobar F, Gómez-Capilla JA and Fárez-Vidal ME:
Survival, classifications, and desmosomal plaque genes in non-small
cell lung cancer. Int J Med Sci. 10:1166–1173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen X, Guan X, Zhang H, Xie X, Wang H,
Long J, Cai T, Li S, Liu Z and Zhang Y: DAL-1 attenuates
epithelial-to mesenchymal transition in lung cancer. J Exp Clin
Cancer Res. 34:32015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Floor S, van Staveren WC, Larsimont D,
Dumont JE and Maenhaut C: Cancer cells in epithelial-to-mesenchymal
transition and tumor-propagating-cancer stem cell: Distinct,
overlapping or same populations. Oncogene. 30:4609–4621. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shih JY and Yang PC: The EMT regulator
slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Liu Y, Liu Z, Wang XM, Yin DT,
Zheng LL, Zhang DY and Lu XB: Differential expression profiling and
functional analysis of microRNAs through stage I–III papillary
thyroid carcinoma. Int J Med Sci. 10:585–592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim LH and Pervaiz S: Annexin 1: The new
face of an old molecule. FASEB J. 21:968–975. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hongsrichan N, Rucksaken R, Chamgramol Y,
Pinlaor P, Techasen A, Yongvanit P, Khuntikeo N, Pairojkul C and
Pinlaor S: Annexin A1: A new immunohistological marker of
cholangiocarcinoma. World J Gastroenterol. 19:2456–2465. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and exression. Nucleic
Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective miroRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
13
|
Anders G, Mackowiak SD, Jens M, Maaskola
J, Kuntzagk A, Rajewsky N, Landthaler M and Dieterich C: doRiNA: A
database of RNA interactions in post-transcriptional regulation.
Nucleic Acids Res. 40:D180–D186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benson DA, Karsch-Mizrachi I, Lipman DJ,
Ostell J and Wheeler DL: GenBank. Nucleic Acids Res. 33:D34–D38.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Altschul SF, Gish W, Miller W, Myers EW
and Lipman DJ: Basic local alignment search tool. J Mol Biol.
215:1–410. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Y, Zhou J, Zhang X, Zheng X, Jiang X,
Shi L, Yin W and Wang J: Optimized sample preparation for
two-dimensional gel electrophoresis of soluble proteins from
chicken bursa of fabricius. Proteome Sci. 7:382009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, Wang N, Zhang M, Xue S, Shi K and
Chen Z: Detaction of methylation of the RAR-β gene in patients with
non-small cell lung cancer. Oncol Lett. 3:654–658. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tran YK, Bögler O, Gorse KM, Wieland I,
Green MR and Newsham IF: A novel member of the NF2/ERM/4.1
superfamily with growth suppressing properties in lung cancer.
Cancer Res. 59:35–43. 1999.PubMed/NCBI
|
|
20
|
Xu RB, Zhang YJ and Guo AL: Primary survey
of effects of DAL-1 in procession of proliferation, migration and
invasion of NSCLC cell line. Chin J Cancer Prev Treat.
16:1139–1143. 2009.(In Chinese).
|
|
21
|
Lee DH, Amanat S, Goff C, Weiss LM, Said
JW, Doan NB, Sato-Otsubo A, Ogawa S, Forscher C and Koeffler HP:
Overexpression of miR-26a-2 in human liposarcoma is correlated with
poor patient survival. Oncogenesis. 2:e472013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lv M, Zhang X, Li M, Chen Q, Ye M, Liang
W, Ding L, Cai H, Fu D and Lv Z: miR-26a and its target CKS2
modulate cell growth and tumorigenesis of papillary thyroid
carcinoma. PLoS One. 8:e675912013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao J, Li L, Wu M, Liu M and Xie X, Guo J,
Tang H and Xie X: miR-26a inhibits proliferation and migration of
breast cancer through repression of MCL-1. PLoS One. 8:e651382013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qian X, Zhao P, Li W, Shi ZM, Wang L, Xu
Q, Wang M, Liu N, Liu LZ and Jiang BH: MicroRNA-26a promotes tumor
growth and angiogenesis in glioma by directly targeting prohibitin.
CNS Neurosci Ther. 19:804–812. 2013.PubMed/NCBI
|
|
25
|
de Graauw M, van Miltenburg MH, Schmidt
MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit
VT, van der Wal A, et al: Annexin A1 regulates TGF-beta signaling
and promotes metastasis formation of basal-like breast cancer
cells. Proc Natl Acad Sci USA. 107:pp. 6340–6345. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suh YE, Raulf N, Gäken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han G, Tian Y, Duan B, Sheng H, Gao H and
Huang J: Association of nuclear annexin A1 with prognosis of
patients with esophageal squamous cell carcinoma. Int J Clin Exp
Pathol. 7:751–759. 2014.PubMed/NCBI
|
|
28
|
Geary LA, Nash KA, Adisetiyo H, Liang M,
Liao CP, Jeong JH, Zandi E and Roy-Burman P: CAF-secreted annexin
A1 induces prostate cancer cells to gain stem cell-like features.
Mol Cancer Res. 12:607–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng SX, Tu Y and Zhang S: FoxM1 promotes
glioma cells progression by up-regulating anxa1 expression. PLoS
One. 8:e723762013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Queiroz CJ, Nakata CM, Solito E and Damazo
A: Relationship between HPV and the biomarkers annexin A1 and p53
in oropharyngeal cancer. Infect Agent Cancer. 9:132014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang Y, Guan X, Cai T, Long J, Wang H, Xie
X and Zhang Y: Knockdown of ANXA1 supresses the biological behavior
of human NSCLC cells in vitro. Mol Med Rep. 13:3858–3866. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Icli B, Wara AK, Moslehi J, Sun X, Plovie
E, Cahill M, Marchini JF, Schissler A, Padera RF, Shi J, et al:
MicroRNA-26a regulates pathological and physiological angiogenesis
by targeting BMP/SMAD1 signaling. Circ Res. 113:1231–1241. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY,
Peng XH, Xu X, Tian WD and Li XP: miR-26a inhibits invasion and
metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett.
5:1223–1228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng M, Tang HL, Lu XH, Liu MY, Lu XM, Gu
YX, Liu JF and He ZM: miR-26a suppresses tumor growth and
metastasis by targeting FGF9 in gastric cancer. PLoS One.
8:e726622013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan S, Ding K, Li R, Zhang W, Li G, Kong
X, Qian P, Lobie PE and Zhu T: Identification of miR-26 as a key
mediator of estrogen stimulated cell proliferation by targeting
CHD1, GREB1 and KPNA2. Breast Cancer Res. 16:R402014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Han C and Wu T: MicroRNA-26a
promotes cholangiocarcinoma growth by activating β-catenin.
Gastroenterology. 143:246–256 e248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghanbari R, Mosakhani N, Asadi J, Nouraee
N, Mowla SJ, Yazdani Y, Mohamadkhani A, Poustchi H, Knuutila S and
Malekzadeh R: Downregulation of plasma MiR-142-3p and MiR-26a-5p in
patients with colorectal carcinoma. Iran J Cancer Prev.
8:e23292015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhuang C, Jiang W, Huang D, Xu L, Yang Q,
Zheng L, Wang X and Hu L: Serum miR-21, miR-26a and miR-101 as
potential biomarkers of hepatocellular carcinoma. Clin Res Hepatol
Gastroenterol. 40:386–396. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ydy LR, do Espirito Santo GF, de Menezes
I, Martins MS, Ignotti E and Damazo AS: Study of the annexin A1 and
its associations with carcinoembryonic antigen and mismatch repair
proteins in colorectal cancer. J Gastrointest Cancer. 47:61–68.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sobral-Leite M, Wesseling J, Smit VT,
Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM,
Coulson P, Patrycja G, et al: Annexin A1 expression in a pooled
breast cancer series: Association with tumor subtypes and
prognosis. BMC Med. 13:1562015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin Y, Lin G, Fang W, Zhu H and Chu K:
Increased expression of annexin A1 predicts poor prognosis in human
hepatocellular carcinoma and enhances cell malignant phenotype. Med
Oncol. 31:3272014. View Article : Google Scholar : PubMed/NCBI
|
